We are excited to announce a strategic partnership between The Ganesha Lab (TGL) and Life Science Nation (LSN) to establish a dedicated biotech accelerator hub in São Paulo, Brazil, by the end of 2025.   

This milestone connects Latin America’s vibrant scientific talent with the global healthcare innovation ecosystem, creating a true two-way bridge for collaboration, scale, and impact. 

What this means for Latin America 

• Regional readiness at scale: Through our BIGinBIO platform, startups will gain world-class mentoring, structured readiness programs, industry connections, and access to early-stage capital. 

• Pathway to global markets: Latin American innovators will integrate into LSN’s global commercialization-first process, gaining direct access to curated investors, licensing partners, and opportunities to present at the renowned RESI Conferences. 

• Inbound innovation: The São Paulo hub will not only scale local ventures globally but also bring international technologies, investors, and pharma partners into Brazil, accelerating validation and market entry.

Why São Paulo? 

As Latin America’s leading innovation hub, São Paulo offers the ideal ecosystem to anchor this initiative. Supported by local institutions, industry leaders, and government, the accelerator will be embedded into Brazil’s national life sciences strategy, leveraging TGL’s regional expertise and LSN’s global backbone. 

 Global + Local = Impact 

• Life Science Nation contributes global reach: a partnering backbone, 4,000+ investor and licensing partner profiles, AI-driven readiness tools, and $5B raised across 400+ companies. 

• The Ganesha Lab brings regional depth: a proven track record of sourcing, mentoring, and scaling Latin American startups internationally, with long-term support through our extensive global network. 

Together, we are creating a seamless pathway: Regional readiness → Global campaign execution → Inbound capital and technologies into Latin America. 

What’s next? 

The São Paulo hub is set to go live by late 2025 / early 2026, becoming the anchor node for Latin America in LSN’s global network, with potential expansion into other regional innovation centers. 

This collaboration will also take center stage at the Biohunt Summit 2025 in Miami, where Markus Schreyer (Founder and CEO, TGL) and Dennis Ford (Founder & CEO, LSN) will share more in an exclusive fireside chat. 

At The Ganesha Lab, we are proud to position Latin America at the forefront of global life sciences. Together with LSN, we are building bridges that empower startups, investors, and healthcare partners on both sides of the world.